Chemical Compound

3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate

CAS Registry Number 477600-75-2
返回搜索 申请报价
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate 结构式
Primary record

3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate

库存
6,318 克
纯度
98.9 %
CAS
477600-75-2

化合物标识与属性

CAS
477600-75-2
PubChem CID
9926791
SMILES
C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N
Canonical SMILES
C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12

名称与同义词

  • Tofacitinib
  • Tasocitinib
  • 477600-75-2
  • rac-Tofacitinib
  • tofacitinibum
  • Xeljanz
  • Tofacitinib citrate
  • Tofactinib
  • Tedalinab
  • Tofacitinib?
  • racemic-tofacitinib
  • racemic-Tasocitinib
  • Tofacitinib Base
  • Cp-690 free base
  • CP-690550
  • 3eyg
  • 3fup
  • 3lxk
  • 4oti
  • Tofacitinib [USAN]
  • Xeljanz (TN)
  • CP 690550
  • Tofacitinib (USAN)
  • (+)-TOFACITINIB
  • 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
  • RefChem:6313
  • Tofacitinib (Standard)
  • Tofacitinib [USAN:INN]
  • TOFACITINIB [MI]
  • TOFACITINIB [INN]
  • D0EG1I
  • D0O2KL
  • C16H20N6O
  • TOFACITINIB [VANDF]
  • UNII-87LA6FU830
  • JAK inhibitors: tofacitinib
  • CHEMBL221959
  • 87LA6FU830
  • CP-690550 FREE BASE
  • Tofacitinib (CP-690550,Tasocitinib)
  • TOFACITINIB [WHO-DD]
  • cc-396
  • CHEBI:71200
  • CP-690550(Tasocitinib)
  • CP-690,550 FREE BASE
  • SCHEMBL322753
  • 1259404-17-5
  • CP-690,550
  • DTXSID90197271
  • MFCD11035919
  • Tofacitinib (CP-690550)
  • GTPL5677
  • orb1300872
  • QCR-53
  • CP690550
  • SCHEMBL29351183
  • CTK3J8304
  • HSDB 8311
  • 477600-75-2 (free base)
  • AMY3992
  • DTXCID00119762
  • EX-A205
  • L04AA29
  • CP-690
  • MFCD11616529
  • MFCD22628813
  • UJLAWZDWDVHWOW-YPMHNXCESA-N
  • BCPP000274
  • GLXC-90307
  • AOB87470
  • KS-000001IG
  • KS-000006RA
  • ZINC3818808
  • CP690,550
  • ABP000824
  • ANW-51607
  • BDBM50193995
  • EBC-11351
  • GRC-10693
  • HY-40354R
  • NSC782351
  • NSC800953
  • s2789
  • Tofacitinib, 99% - 10MG 10mg
  • CP-690-550
  • AKOS005145814
  • AKOS005258733
  • AC-8193
  • ACN-031566
  • AT43433
  • BCP9000550
  • CA10005
  • CC-1770
  • CCG-264998
  • CID9926791
  • CS-0050
  • DB08895
  • FT32555
  • GS-6106
  • NSC-782351
  • NSC-800953
  • RL03781
  • SDCCGSBI-0654407.P002
  • CID 9926791
  • NCGC00229511-02
  • NCGC00229511-04
  • NCGC00229511-10
  • NCGC00229511-25
  • NCGC00244463-01
  • Tofacitinib (CP-690550, Tasocitinib)
  • AJ-45724
  • BC660087
  • CP690550(Tasocitinib)/CP-690550
  • HY-40354
  • SC-21829
  • 3-((3R,4R)-rel-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
  • AB0007916
  • TR-009964
  • TX-016530
  • A4138
  • A7301
  • NS00069315
  • W6440
  • 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile
  • CP- 690 550
  • J2.740.060D
  • D09970
  • Q-9324
  • AB01565786_02
  • EN300-1718468
  • 600M752
  • AR-270/43507983
  • Q3530324
  • BRD-K31283835-001-01-9
  • BRD-K31283835-048-04-4
  • 3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
  • 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile
  • 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyr
  • B0084-453466
  • 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-, (3R,4R)-
  • 3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
  • 3-Piperidinamine, 1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo(2,3-d)pyrimidin-4-yl-, (3R,4R)-
  • 212143-23-2
  • 3-(4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
  • 3-[(3R*,4R*)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
  • 3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidyl]-3-oxo-propanenitrile
  • 3-{(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile
  • 3-((3R,4R)-4-Methyl(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yi)Amino)Piperidin-1-Yl-3-Oxopropaneni
  • (3R)-beta-Oxo-3alpha-[7H-pyrrolo[2,3-d]pyrimidine-4-yl(methyl)amino]-4alpha-methylpiperidine-1-propanenitrile
  • (3R,4R)-1-(Cyanoacetyl)-4,N-dimethyl-N-(1H-pyrrolo[2,3-d]pyrimidine-4-yl)-3-piperidineamine
  • (3R,4R)-3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile
  • (3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidine propanenitrile
  • (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile
  • (3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidine-4-yl)amino]-beta-oxo-1-piperidinepropanenitrile
  • 1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-.BETA.-OXO-, (3R,4R)-
  • 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-|A-oxo-, (3R,4R)-
  • 3-((3R,4R)-4-methyl-3-(methyl((7H-pyrrolo(2,3-d)pyrimidin-4-yl))amino)piperidin-1-yl)-3-oxopropanenitrile
  • 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitr
  • 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate
  • 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile citrate
  • 3-[(3R,4R)-4-Methyl-3-[N-methyl(7H-pyrrolo[2,3-d]pyrimidine-4-yl)amino]piperidine-1-yl]-3-oxopropanenitrile
  • 3-[3alpha-[Methyl(7H-pyrrolo[2,3-d]pyrimidine-4-yl)amino]-4alpha-methylpiperidino]-3-oxopropionitrile
  • 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]piperidin-1-yl}-3-oxo-propionitrile
  • 3-{(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile
  • 3-{4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-3-oxopropanenitrile
  • 540737-29-9
  • 689-145-4
  • 916591-01-0
  • 937669-80-2
  • dichloro[(r)-(+)-2,2-bis(diphenylphosphino)-1,1-binaphthyl][(1r,2r)-(+)-1,2-diphenylethylenediamine]
  • dichloro[(r)-(+)-2,2-bis(diphenylphosphino)-1,1-binaphthyl][(1r,2r)-(+)-1,2-diphenylethylenediamine]ruthenium(ii)
  • MI1
  • N-Methyl-N-[(3R)-1-(cyanoacetyl)-4alpha-methylpiperidine-3alpha-yl]-7H-pyrrolo[2,3-d]pyrimidine-4-amine
  • REL-3-((3R,4R)-4-METHYL-3-(METHYL(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO)PIPERIDIN-1-YL)-3-OXOPROPANENITRILE
  • Tofacitinib; 3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
  • Tofacitinib;3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile